DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis

Shan Jin1, Chang Ook Park, Jung U Shin

  • 1Department of Dermatology & Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea; Department of Dermatology, Yanbian University Hospital, Yanji, Jilin, China.

Experimental Dermatology
|October 14, 2014
PubMed

Insights

Damage-associated molecular pattern (DAMP) molecules S100A9 and S100A8 are elevated in atopic dermatitis (AD). IL-17A and house dust mites significantly increase their expression, suggesting a role in AD pathogenesis.

Area of Science:

  • Immunology
  • Dermatology
  • Molecular Biology

Background:

  • S100A9 and S100A8 are pro-inflammatory damage-associated molecular pattern (DAMP) molecules.
  • Their role as DAMPs in atopic dermatitis (AD) requires further investigation.

Discussion:

  • House dust mite (Dermatophagoides farinae) and IL-17A synergistically induce S100A9 and S100A8 expression in keratinocytes.
  • S100A9 treatment dose-dependently increases IL-33 mRNA levels in keratinocytes.
  • S100A8/A9 levels correlate with disease severity in AD patients' skin and serum.

Key Insights:

  • S100A9 and S100A8 are significantly upregulated in AD.
  • IL-17A and house dust mite exposure are key drivers of S100A9/S100A8 induction in AD.
  • These DAMPs may contribute to IL-33-mediated inflammation in AD.

Outlook:

  • Further research into S100A9/S100A8 as therapeutic targets in AD.
  • Investigating the precise mechanisms of S100A9/S100A8 in keratinocyte-cytokine crosstalk.
  • Exploring the role of IL-17A in exacerbating AD through S100A9/S100A8 induction.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Allergic Reactions02:06

Allergic Reactions

Overview
25.9K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
26
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K